Catalyst Wire Dossier Catalyst Wire Dossier

Feminizing hormone therapy

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Feminizing hormone therapy, covering 2024-11-25 to 2024-11-25. Get the full timeline:

Most recent: Clinical Trial Update: Assessment of Drug-drug Interactions Between Feminizing Hormone Therapy and Emtricitabine/Tenofovir Alafenamide Concomitantly for Pre-exposure Prophylaxis Among Transgender Women [NA]

See pricing